MNMeagan Y. Nakamoto

Meagan Y. Nakamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meagan Y. Nakamoto has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation

    by Ava C. Carter, Jin Xu, Meagan Y. Nakamoto, Yuning Wei, Quanming Shi, James P. Broughton, Ryan C. Ransom, Ankit Salhotra, Surya D. Nagaraja, Rui Li, et al.

    Dosage compensation between the sexes has emerged independently multiple times during evolution, often harnessing long noncoding RNAs (lncRNAs) to alter gene expression on the sex chromosomes. In eutherian mammals, X chromosome inactivation (XCI) in females proceeds via the lncRNAXist, which coats one of the two X chromosomes and recruits repressive proteins to epigenetically silence gene expressionin cis1,2. HowXistevolved new functional RNA domains to recruit ancient, pleiotropic protein partners is of great interest. Here we show that Spen, anXist-binding repressor protein essential for XCI3-7, binds to ancient retroviral RNA, performing a surveillance role to recruit chromatin silencing machinery to these parasitic loci.Speninactivation leads to de-repression of a subset of endogenous retroviral (ERV) elements in embryonic stem cells, with gain of chromatin accessibility, active histone modifications, andERVRNA transcription. Spen binds directly toERVRNAs that show structural similarity to the A-repeat ofXist, a region critical forXist-mediated gene silencing8-9.ERVRNA andXistA-repeat bind the RRM3 domain of Spen in a competitive manner. Insertion of an ERV into an A-repeat deficientXistrescues binding ofXistRNA to Spen and results in local gene silencingin cis. These results suggest that insertion of an ERV element into proto-Xistmay have been a critical evolutionary event, which allowedXistto coopt transposable element RNA-protein interactions to repurpose powerful antiviral chromatin silencing machinery for sex chromosome dosage compensation.